dicloxacillin has been researched along with rifampin in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (23.53) | 18.7374 |
1990's | 2 (11.76) | 18.2507 |
2000's | 4 (23.53) | 29.6817 |
2010's | 5 (29.41) | 24.3611 |
2020's | 2 (11.76) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Blom, J; Frimodt-Møller, N; Hessler, JH; Sandberg, A; Skov, RL | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Barber, J; Dawson, S; Kenna, JG; Paul, N; Stahl, S | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Fomina, IP; Kuznetsova, SM; Speranskaia, ON | 1 |
Buogo, A; Cattaneo, P; Zanuso, G | 1 |
Archer, G; Bornholm, J; Yu, VL; Zuravleff, JJ | 1 |
Høiby, N; Szaff, M | 1 |
Erlendsdóttir, H; Gottfredsson, M; Gudmundsson, A; Gudmundsson, S | 1 |
Black, FT; Nielsen, SL | 1 |
Egeberg, A; Frew, JW; Ingram, JR; Maul, JT; Nielsen, ML; Ring, HC; Thomsen, SF; Thorsen, J; Thyssen, JP; Wu, JJ; Yao, Y | 1 |
Bock, M; Bruun, NE; Bundgaard, H; Christensen, JJ; Christiansen, U; Elming, H; Fosbøl, EL; Fuursted, K; Gill, S; Helweg-Larsen, J; Høfsten, D; Høiby, N; Ihlemann, N; Iversen, K; Kristensen, JH; Køber, L; Lemming, L; Lerche, CJ; Moser, C; Nielsen, HL; Pedersen, CT; Povlsen, JA; Pries-Heje, MM; Rosenvinge, FS; Schultz, M; Theut, AM; Tønder, N; van Hasselt, JGC; Wang, H | 1 |
1 review(s) available for dicloxacillin and rifampin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
16 other study(ies) available for dicloxacillin and rifampin
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Intracellular activity of antibiotics against Staphylococcus aureus in a mouse peritonitis model.
Topics: Animals; Animals, Outbred Strains; Anti-Bacterial Agents; Colony Count, Microbial; Dicloxacillin; Dose-Response Relationship, Drug; Female; Humans; Mice; Microbial Sensitivity Tests; Peritoneum; Peritonitis; Rifampin; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Humans; Insecta; Rats; Risk Factors | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Methicillin-resistant staphylococci: biological properties and sensitivity to antibiotics].
Topics: Ampicillin; Anti-Bacterial Agents; Carbenicillin; Cephaloridine; Chloramphenicol; Dicloxacillin; Erythromycin; Fusidic Acid; Gentamicins; Kanamycin; Methicillin; Oxacillin; Penicillin G; Penicillin Resistance; Penicillinase; Rifampin; Staphylococcus; Streptomycin; Tetracycline; Vancomycin | 1973 |
[Comparison of the antibacterial action in vitro of a combination of penicillins and other antibiotics on 127 strains isolated in an oncological institute].
Topics: Ampicillin; Bacteria; Cephaloridine; Dicloxacillin; Drug Combinations; Microbial Sensitivity Tests; Penicillins; Rifampin | 1973 |
In-vitro synergy testing of triple antibiotic combinations against Staphylococcus epidermidis isolates from patients with endocarditis.
Topics: Anti-Bacterial Agents; Dicloxacillin; Drug Combinations; Drug Synergism; Endocarditis, Bacterial; Fusidic Acid; Gentamicins; Humans; Microbial Sensitivity Tests; Rifampin; Staphylococcus epidermidis; Vancomycin | 1984 |
Antibiotic treatment of Staphylococcus aureus infection in cystic fibrosis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Child, Preschool; Cystic Fibrosis; Dicloxacillin; Female; Fusidic Acid; Humans; Infant; Male; Oxacillin; Probenecid; Pseudomonas Infections; Rifampin; Staphylococcal Infections | 1982 |
Different patterns of bacterial DNA synthesis during postantibiotic effect.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Dicloxacillin; DNA, Bacterial; Escherichia coli; Gentamicins; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Rifampin; Staphylococcus aureus; Tobramycin; Vancomycin | 1995 |
Extracellular and intracellular killing in neutrophil granulocytes of Staphylococcus aureus with rifampicin in combination with dicloxacillin or fusidic acid.
Topics: Adult; Dicloxacillin; Drug Therapy, Combination; Fusidic Acid; Humans; Microbial Sensitivity Tests; Neutrophils; Rifampin; Staphylococcus aureus | 1999 |
The road to biologics in patients with hidradenitis suppurativa: a nationwide drug utilization study.
Topics: Acitretin; Anti-Bacterial Agents; Biological Factors; Biological Products; Clindamycin; Dapsone; Dicloxacillin; Drug Utilization; Hidradenitis Suppurativa; Humans; Isotretinoin; Rifampin; Tetracyclines | 2022 |
Attainment of Target Antibiotic Levels by Oral Treatment of Left-Sided Infective Endocarditis: A POET Substudy.
Topics: Amoxicillin; Anti-Bacterial Agents; Dicloxacillin; Endocarditis; Endocarditis, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Rifampin | 2023 |